Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Leishmania guyanensis suppressed inducible nitric oxide synthase provoked by its viral endosymbiont

Frontiers in Cellular and Infection Microbiology(2022)10.3389/fcimb.2022.944819Source: DataRank Database

Leishmania guyanensis suppressed inducible nitric oxide synthase provoked by its viral endosymbiont is a research paper published in Frontiers in Cellular and Infection Microbiology (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.74)OA: goldTopics (47)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Chantal Desponds,Florence Prével,Matteo A. C. Rossi ORCID,Romain Migliorini,Tiia Snäkä ORCID

Live enrichment

PubMed:36034693 PMC:PMC9416488 OpenAlex:https://openalex.org/W4290861339

NIAID NIH HHS

Grant: R01 AI029646

NIAID NIH HHS

Grant: R01 AI031078

NIAID NIH HHS

Grant: R01 AI130222

Foundation for the National Institutes of Health

Grant: R01AI-31078, R01AI-30222-02

Swiss National Science Foundation

Grant: 310030_173180, IZRJZ3_164176/1

FWCI

1.74

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fcimb.2022.944819

publisherhttps://doi.org/10.3389/fcimb.2022.944819

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36034693

repositoryhttps://serval.unil.ch/notice/serval:BIB_A72D8B03FFC4

repositoryhttps://iris.unil.ch/handle/iris/190093

Fields of Study

Research on Leishmaniasis StudiesTrypanosoma species research and implicationsBurkholderia infections and melioidosisAnimalsCytokinesHumansInterleukin-17LeishmaniaLeishmania guyanensisLeishmaniavirusMiceNF-kappa BNitric OxideNitric Oxide Synthase Type IIToll-Like Receptor 3Leishmania RNA virus 1

MeSH Terms

AnimalsHumansLeishmaniaNitric OxideCytokinesNF-kappa BLeishmania guyanensisLeishmaniavirusInterleukin-17Toll-Like Receptor 3MiceNitric Oxide Synthase Type II

Keywords

Nitric oxideNitric oxide synthaseEffectorIntracellularBiologyMicrobiologyLeishmaniasisChemistryVirologyImmunologyCell biologyLeishmaniaMetastasisInducible nitric oxide synthase (iNOS)Type I interferonsIl-17aNuclear Factor Kappa-light-chain-enhancer Of Activated B Cells (Nf-kb)Leishmania Rna Virus 1 (Lrv1)Tumor Necrosis Factor-Alpha-Induced Protein 3 (A20)

Sustainable Development Goals

SDG 0: Good health and well-being